Comparison of Predicted Cardiovascular Risk Profiles by Different CVD Risk-Scoring Algorithms between HIV-1-Infected and Uninfected Adults: A Cross-Sectional Study in Tanzania

References

• UNAIDS. Global HIV and AIDS Statistics 2019 Fact Sheet; 2019.
   Google Scholar
• Njelekela M, Muhihi A, Aveika A, et al. Prevalence of hypertension and its associated risk factors among 34,111 HAART naïve HIV-infected adults in Dar es Salaam, Tanzania. Int J Hypertens. 2016;2016:5958382. doi:10.1155/2016/5958382
   Web of Science ®Google Scholar
• Triant VA, Perez J, Regan S, et al. Cardiovascular risk prediction functions underestimate risk in HIV infection. Circulation. 2018;137(21):2203–2214. doi:10.1161/CIRCULATIONAHA.117.028975
   PubMed Web of Science ®Google Scholar
• Msoka TF, Van Guilder GP, Smulders YM, van Furth M, Bartlett JA, van Agtmael MA. Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study. BMC Infect Dis. 2018;18(1):708. doi:10.1186/s12879-018-3637-0
   Web of Science ®Google Scholar
• Msoka TF, Van Guilder GP, Smulders YM, van Furth M, Bartlett JA, van Agtmael MA. Antiretroviral treatment and time since HIV-1 diagnosis are associated with large artery stiffness in sub-Saharan African HIV-1 patients. Artery Res. 2016;16:34–41. doi:10.1016/j.artres.2016.09.002
   Web of Science ®Google Scholar
• Rose H, Low H, Dewar E, et al. The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study. Atherosclerosis. 2013;229(1):206–211.
   Web of Science ®Google Scholar
• Touloumi G, Kalpourtzi N, Papastamopoulos V, et al. Cardiovascular risk factors in HIV infected individuals: comparison with general adult control population in Greece. PLoS One. 2020;15(3):e0230730. doi:10.1371/journal.pone.0230730
   PubMed Web of Science ®Google Scholar
• Kim SB, Kim YC, Kim MH, et al. A comparison of the predicted risk for cardiovascular disease between HIV-infected and uninfected persons in Korea. Scand J Infect Dis. 2013;45(11):855–862. doi:10.3109/00365548.2013.813064
   PubMed Web of Science ®Google Scholar
• Bergersen BM, Sandvik L, Bruun JN, Tonstad S. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Eur J Clin Microbiol Infect Dis. 2004;23(8):625–630. doi:10.1007/s10096-004-1177-6
   PubMed Web of Science ®Google Scholar
• Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med. 2012;13(8):453–468. doi:10.1111/j.1468-1293.2012.00996.x
   PubMed Web of Science ®Google Scholar
• Policarpo S, Rodrigues T, Moreira AC, Valadas E. Cardiovascular risk in HIV-infected individuals: a comparison of three risk prediction algorithms. Rev Port Cardiol. 2019;38(7):463–470. doi:10.1016/j.repc.2019.08.002
   Google Scholar
• Muiru AN, Bibangambah P, Hemphill L, et al. Distribution and performance of cardiovascular risk scores in a mixed population of HIV-infected and community-based HIV-uninfected individuals in Uganda. J Acquir Immune Defic Syndr. 2018;78(4):458–464. doi:10.1097/QAI.0000000000001696
   PubMed Web of Science ®Google Scholar
• Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1 Pt 2):293–298. doi:10.1016/0002-8703(91)90861-B
   PubMed Web of Science ®Google Scholar
• Menon VP, Edathadathil F, Sathyapalan D, et al. Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study. Medicine. 2016;95(49):e5542. doi:10.1097/MD.0000000000005542
   Web of Science ®Google Scholar
• MacDonald SE, Walker M, Ramshaw H, Godwin M, Chen XK, Smith GN. Hypertensive disorders of pregnancy and long-term risk of hypertension: what do ontario prenatal care providers know and what do they communicate? J Obstet Gynaecol Can. 2007;29(9):705–710. doi:10.1016/S1701-2163(16)32601-9
   Google Scholar
• Naschitz JE, Lenger R. Why traumatic leg amputees are at increased risk for cardiovascular diseases. Q J Med. 2008;101:251–259. doi:10.1093/qjmed/hcm131
   Google Scholar
• Bhatnagar V, Richard E, Melcer T, Walker J, Galarneau M. Retrospective study of cardiovascular disease risk factors among a cohort of combat veterans with lower limb amputation. Vasc Health Risk Manag. 2019;15. doi:10.2147/VHRM.S212729
   Web of Science ®Google Scholar
• Raphael DM, Roos L, Myovela V, et al. Heart diseases and echocardiography in rural Tanzania: occurrence, characteristics, and etiologies of underappreciated cardiac pathologies. PLoS One. 2018;13(12):e0208931. doi:10.1371/journal.pone.0208931
   Web of Science ®Google Scholar
• Shah ASV, Stelzle D, Lee KK, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis. Circulation. 2018;138(11):1100–1112. doi:10.1161/CIRCULATIONAHA.117.033369
   PubMed Web of Science ®Google Scholar
• Tremblay AJ, Morrissette H, Gagné JM, Bergeron J, Gagné C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem. 2004;37(9):785–790. doi:10.1016/j.clinbiochem.2004.03.008
   PubMed Web of Science ®Google Scholar
• Handler J, Zhao Y, Egan BM. Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999–2008. J Clin Hypertens. 2012;14:751–759. doi:10.1111/jch.12009
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
   PubMed Web of Science ®Google Scholar
• Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. Circulation. 2014;129(25_suppl_2):S49–S73. doi:10.1161/01.cir.0000437741.48606.98
   PubMed Web of Science ®Google Scholar
• Hinkle DE, Wiersma W, Jurs SG. Applied Statistics for the Behavioral Sciences. 5th ed. Boston: Hugton Miffin College Division; 2003.
   Google Scholar
• Cortés YI, Reame N, Zeana C, et al. Cardiovascular risk in HIV-infected and uninfected postmenopausal minority women: use of the Framingham risk score. J Womens Health. 2017;26(3):241–248. doi:10.1089/jwh.2015.5736
   PubMed Web of Science ®Google Scholar
• De Socio GV, Martinelli L, Morosi S, et al. Is estimated cardiovascular risk higher in HIV-infected patients than in the general population? Scand J Infect Dis. 2007;39(9):805–812. doi:10.1080/00365540701230884
   PubMed Web of Science ®Google Scholar
• Kakinami L, Block RC, Adams MJ, Cohn SE, Maliakkal B, Fisher SG. Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population. Int J Clin Pract. 2013;67(1):6–13. doi:10.1111/j.1742-1241.2012.02953.x
   Web of Science ®Google Scholar
• Low H, Hoang A, Pushkarsky T, et al. HIV disease, metabolic dysfunction and atherosclerosis: a three year prospective study. PLoS One. 2019;14(4):e0215620. doi:10.1371/journal.pone.0215620
   Web of Science ®Google Scholar
• Osegbe ID, Soriyan OO, Ogbenna AA, Okpara HC, Azinge EC. Risk factors and assessment for cardiovascular disease among HIV-positive patients attending a Nigerian tertiary hospital. Pan Afr Med J. 2016;23:206. doi:10.11604/pamj.2016.23.206.7041
   Google Scholar
• Mosepele M, Hemphill LC, Palai T, et al. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa. PLoS One. 2017;12(2):e0172897. doi:10.1371/journal.pone.0172897
   Web of Science ®Google Scholar
• Boateng D, Agyemang C, Beune E, et al. Cardiovascular disease risk prediction in sub-Saharan African populations - comparative analysis of risk algorithms in the RODAM study. Int J Cardiol. 2018;254:310–315. doi:10.1016/j.ijcard.2017.11.082
   Web of Science ®Google Scholar
• Damen JA, Hooft L, Schuit E, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ. 2016;353:i2416. doi:10.1136/bmj.i2416
   PubMed Web of Science ®Google Scholar
• Bazo-Alvarez JC, Quispe R, Peralta F, et al. Agreement between cardiovascular disease risk scores in resource-limited settings: evidence from 5 peruvian sites. Crit Pathw Cardiol. 2015;14(2):74–80. doi:10.1097/HPC.0000000000000045
   PubMedGoogle Scholar
• Oulhaj A, Bakir S, Aziz F, et al. Agreement between cardiovascular disease risk assessment tools: an application to the United Arab Emirates population. PLoS One. 2020;15(1):e0228031. doi:10.1371/journal.pone.0228031
   Web of Science ®Google Scholar
• Ancheta IB, Battie CA, Volgman AS, Ancheta CV, Latha Palaniappan L. Cardiovascular disease risk score: results from the Filipino–American Women Cardiovascular Study. J Racial Ethn Health Disparities. 2015. doi:10.1007/s40615-015-0196-6
   Web of Science ®Google Scholar
• Gaikwad A, Khan Y. Evaluation of discordance between 10 year cardiovascular risk scores in Indian patients presenting with myocardial infarction. Cardiol Cardiovasc Med. 2019;3(05):360–368. doi:10.26502/fccm.92920085
   Google Scholar
• Wekesah FM, Mutua MK, Boateng D, et al. Comparative performance of pooled cohort equations and Framingham risk scores in cardiovascular disease risk classification in a slum setting in Nairobi Kenya. IJC Heart Vasculature. 2020;28:100521. doi:10.1016/j.ijcha.2020.100521
   Web of Science ®Google Scholar
• Motamed N, Mardanshahi A, Saravi BM, Siamian H, Maadi M, Zamani F. The 10-year absolute risk of Cardiovascular (CV) events in Northern Iran: a Population Based Study. Mater Sociomed. 2015;27(3):158–162. doi:10.5455/msm.2015.27.158-162
   Google Scholar
• Ofori S, Dodiyi-Manuel S, Akpa MR. Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease. J Clin Lipidol. 2017;11(6):1441–1447. doi:10.1016/j.jacl.2017.09.004
   Web of Science ®Google Scholar
• Korten V, Gökengin D, Yildirmak T, et al. Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) in HIV infected patients. Open Forum Infect Dis. 2017;4(1):S215–S215. doi:10.1093/ofid/ofx163.432
   Google Scholar
• Neto LFSP, Dias FR, Bressan FF, Santos CRO. Comparison of the ACC/AHA and Framingham algorithms to assess cardiovascular risk in HIV-infected patients. Braz j Infect Dis. 2017;21(6):577–580. doi:10.1016/j.bjid.2017.06.007
   Web of Science ®Google Scholar
• Mubiru F, Castelnuovo B, Reynolds SJ, et al. Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests? PLoS One. 2021;16(1):e0243552. doi:10.1371/journal.pone.0243552
   Web of Science ®Google Scholar
• Shrout PE. Measurement reliability and agreement in psychiatry. Stat Methods Med Res. 1998;7(3):301–317. doi:10.1177/096228029800700306
   PubMedGoogle Scholar
• VanderWeele TJ, Robinson WR. On the causal interpretation of race in regressions adjusting for confounding and mediating variables. Epidemiology. 2014;25(4):473–484. doi:10.1097/EDE.0000000000000105
   PubMed Web of Science ®Google Scholar
• Kaufman JS, Cooper RS. Commentary: considerations for use of racial/ethnic classification in etiologic research. Am J Epidemiol. 2001;154:291–298. doi:10.1093/aje/154.4.291
   PubMed Web of Science ®Google Scholar
• Krieger N. Social Epidemiology. New York: Oxford University Press, Discrimination and health inequities; 2014:63–125.
   Google Scholar
• Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. doi:10.1136/bmj.j2099
   PubMed Web of Science ®Google Scholar
• Paulus JK, Wessler BS, Lundquist CM, Kent DM. Effects of race are rarely included in clinical prediction models for cardiovascular disease. J Gen Intern Med. 2018;33(9):1429–1430. doi:10.1007/s11606-018-4475-x
   Web of Science ®Google Scholar
• Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17:143–152.
   PubMed Web of Science ®Google Scholar